Basic and Translational Cancer Research

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Three investigators in a lab

CRCHD supports the following basic and translational research funding opportunities to increase scientific understanding of cancer as well as reduce cancer health disparities. 

Basic Cancer Biology Research

Basic cancer research focuses on biological mechanisms related to cancer.

CRCHD offers two funding opportunities which focus on investigating biological variations across racially and ethnically diverse populations that may contribute to cancer disparities directly or in conjunction with environmental exposures.

A third opportunity focuses broadly on advancing cancer research while promoting diversity of the health-related research workforce.

Title & CRCHD Contact Application Due Date & Purpose

Basic Cancer Research in Cancer Health Disparities (R01)

Dr. Tiffany Wallace
240-276-5114

Due Date: June 17 and November 17

Supports basic research innovative studies designed to investigate biological/genetic bases of cancer disparities.

Exploratory/Developmental Grants Program for Basic Cancer Research in Cancer Health Disparities (R21)

Dr. Tiffany Wallace
240-276-5114

Due Date: June 17 and November 17

Supports basic research pilot and feasibility studies on the biological/genetic causes and mechanisms of cancer health disparities.

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21)

Dr. Abigail Soyombo
240-276-6553

Due Date: June 22 and November 30

Supports eligible investigators from underrepresented groups to conduct research projects focused on the basic biology of cancer.

Translational Cancer Research

Translational research focuses on moving basic research findings into the clinic to advance cancer therapy.

CRCHD offers the following translational research funding opportunities which focus on reducing cancer health disparities.

Title & CRCHD Contact

Application Due Date & Purpose

Minority Patient-Derived Xenograft (PDX) Development and Trial Centers (M-PDTCs) (U54)

Dr. Tiffany Wallace
240-276-5114

Due Date: January 18, 2018

Solicits applications for Minority PDX Development and Trial Centers (M-PDTCs) to join the PDTC Research Network (PDXNet) to expand and diversify the PDXNet. These M-PDTCs will develop and conduct pre-clinical testing of models derived from racial/ethnic minority populations.

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20)

Dr. Tiffany Wallace
240-276-5114

Due Date: January 18, 2018

Supports feasibility and planning activities to develop translational research programs focused on cancer health disparities research with the expectation that the research programs will become competitive for a full Specialized Programs of Research Excellence Specialized Programs (SPORE) award.

  • Updated: November 3, 2017